Brief: Chemometec Says Full-Year Guidance Maintained
Feb 5 (Reuters) - Chemometec A/S CHEMM.CO :
* INTERIM REPORT 2023/24 - FULL-YEAR GUIDANCE MAINTAINED
DESPITE
CONTINUED CHALLENGING MARKET CONDITIONS
* REVENUE WAS DOWN 15% IN Q2 OF 2023/24 TO DKK 108.1 MILLION
FROM
DKK 126.8 MILLION IN YEAR-EARLIER PERIOD
* EBITDA FOR Q2 FELL BY 36% TO DKK 93.1 MILLION, AND EBITDA
MARGIN
WAS 48%, COMPARED WITH 63% IN YEAR-EARLIER PERIOD
Source text for Eikon: ID:nGNEbq3WYD
Further company coverage: CHEMM.CO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ChemoMetec A/S
See all newsDenmark's Chemometec Q1 revenue rises 28% on instrument sales
Brief: Chemometec Q1 EBITDA DKK 100.3 Million
Denmark's ChemoMetec lifts FY outlook on strong instrument demand, lower costs
Brief: Chemometec Raises 2026/27 EBITDA Guidance To DKK 335-360 Million
Brief: Chemometec A/S Says Board Initiates Share Buy-Back Based On AGM Authorisation